OPRX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OPRX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
OptimizeRx has the Growth Rank of 9.
GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:
1. 5-year revenue growth rate, the higher, the better.GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.
Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.
For the Health Information Services subindustry, OptimizeRx's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, OptimizeRx's Growth Rank distribution charts can be found below:
* The bar in red indicates where OptimizeRx's Growth Rank falls into.
Thank you for viewing the detailed overview of OptimizeRx's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Marion Odence-ford | officer: General Counsel and CCO | 400 WATER STREET, SUITE 200, ROCHESTER MI 48307 |
Theresa Greco | officer: Chief Commercial Officer | 260 CHARLES STREET, SUITE 302, WALTHAM MA 02153 |
Doug Besch | officer: Chief Product Officer | 400 WATER STREET, SUITE 200, ROCHESTER MI 48307 |
William J Febbo | officer: Chief Executive Officer | 600 CALIFORNIA ST., 9TH FLOOR, SAN FRANCISCO CA 94108 |
James Paul Lang | director | C/O BIOVIE, 2120 COLORADO AVENUE, SUITE 230, SANTA MONICA CA 90404 |
Stephen L Silvestro | officer: Chief Commercial Officer | 400 WATER STREET, SUITE 200, ROCHESTER MI 48307 |
Ellen O'connor Vos | director | C/O NTELOS HOLDINGS CORP., 1154 SHENANDOAH VILLAGE DRIVE, WAYNESBORO VA 22980 |
Edward Stelmakh | officer: COO and CFO | 400 WATER STREET, SUITE 200, ROCHESTER MI 48307 |
Miriam J Paramore | officer: President | 400 WATER STREET, SUITE 200, ROCHESTER MI 48307 |
Patrick D Spangler | director, officer: SVP of Product & Strategy | 14405 21ST AVENUE NORTH, MINNEAPOLIS MN 55447 |
Douglas P Baker | officer: Chief Financial Officer | 400 WATER STREET, SUITE 200, ROCHESTER MI 48307 |
Todd Inman | officer: Chief Technology Officer | 400 WATER STREET, SUITE 200, ROCHESTER MI 48307 |
Gregory D Wasson | director | 200 WILMOT ROAD, DEERFIELD IL 60015 |
Gus D Halas | director | 38 PHEASANT RUN PLACE, DANVILLE CA 94506 |
Awm Investment Company, Inc. | 10 percent owner | 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 07-03-2022
By PurpleRose PurpleRose • 07-13-2022
By sperokesalga sperokesalga • 02-23-2023
By Marketwired • 10-12-2023
By sperokesalga sperokesalga • 03-29-2023
By GuruFocus Research • 11-06-2023
By GuruFocusNews GuruFocusNews • 07-06-2022
By Marketwired • 09-26-2023
By PurpleRose PurpleRose • 08-23-2022
By GuruFocusNews GuruFocusNews • 06-29-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.